ASPSCR1 and papillary renal cell carcinoma: Moreover, ASPSCR1-TFE3 in alveolar soft part sarcomas and papillary renal cell carcinomas, and YAP1-TFE3 in epithelioid hemangioendotheliomas have been demonstrated [2].